Hybrid Conferencee

International Conference on Cancer Biology and Therapeutics (ICCBT - 26)

5th - 6th September 2026 | Ilheus, Brazil

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Ilheus. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Ilheus event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Ilheus conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Ilheus, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Ilheus."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Tumor Suppressor Genes and Their Role in Cancer

This track will explore the mechanisms by which tumor suppressor genes contribute to cancer development and progression. Discussions will include recent discoveries and their implications for therapeutic strategies.

Track 02

Protein Kinases in Signal Transduction

Focusing on the role of protein kinases in cellular signaling pathways, this track will address their significance in cancer biology. Participants will examine how aberrations in these pathways can lead to tumorigenesis.

Track 03

Steroids and Their Receptors in Cancer

This session will delve into the interactions between steroids and their receptors, highlighting their influence on cancer cell behavior. The implications for targeted therapies and treatment resistance will also be discussed.

Track 04

Transgenic Mice Models in Cancer Research

This track will present the latest advancements in the use of transgenic mice for studying cancer biology. Participants will discuss the advantages and challenges of these models in preclinical research.

Track 05

Apoptosis and Cancer: Mechanisms and Therapeutic Targets

Exploring the intricate relationship between apoptosis and cancer, this session will highlight novel therapeutic targets aimed at restoring apoptotic pathways. The potential for enhancing cancer treatment through apoptosis modulation will be emphasized.

Track 06

RNA Interference in Cancer Biology and Treatment

This track will focus on the application of RNA interference as a therapeutic strategy in cancer treatment. Participants will discuss recent advancements and challenges in translating RNAi technology into clinical practice.

Track 07

Tumor Virology: Implications for Cancer Therapy

This session will investigate the role of viral infections in cancer development and their potential as therapeutic agents. Discussions will include oncolytic viruses and their application in targeted cancer therapies.

Track 08

Carcinogenesis and Mutagenesis: Molecular Insights

Focusing on the molecular mechanisms underlying carcinogenesis and mutagenesis, this track will explore how genetic and environmental factors contribute to cancer initiation. The implications for prevention and treatment will be highlighted.

Track 09

Advances in Cancer Science and Therapy

This session will showcase cutting-edge research and innovations in cancer science and therapeutic approaches. Participants will discuss the integration of new technologies in enhancing treatment efficacy.

Track 10

Integrative Approaches in Cancer Science

This track will emphasize the importance of integrative methodologies in cancer research, combining insights from various disciplines. Discussions will focus on how these approaches can lead to more effective cancer therapies.

Track 11

Anti-Cancer Drug Discovery and Development

Focusing on the latest strategies in anti-cancer drug discovery, this session will cover novel compounds and their mechanisms of action. Participants will discuss the challenges and successes in bringing new therapies to the clinic.